SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-18 |
| Reported value | $177,260,827 |
| Positions | 87 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| VERASTEM INC | VSTM | COM NEW | $12,795,575 | 3,349,627 |
| EVOLUS INC | EOLS | COM | $11,035,724 | 1,590,162 |
| TENAX THERAPEUTICS INC | TENX | COM NEW | $9,603,000 | 660,000 |
| NEKTAR THERAPEUTICS | NKTR | COM NEW | $8,422,856 | 120,654 |
| ADMA BIOLOGICS INC | ADMA | COM | $7,950,000 | 650,000 |
| ADMA BIOLOGICS INC | ADMA | COM | $6,193,800 | 740,000 |
| CAMP4 THERAPEUTICS CORP | CAMP | COM 13469V AB 4 CAMTEK LTD NOTE 12/0 | $6,072,648 | 1,389,622 |
| INSMED INC | INSM | COM PAR $.01 | $5,600,000 | 40,000 |
| ELOXX PHARMACEUTICALS INC | ELOX | COM NEW | $5,512,581 | 397,160 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | COM | $5,500,000 | 200,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.